Notice of Republication
The article titled "GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study"1 which was first published in International Journal of Hematology-Oncology and Stem Cell Research, Volume 9, Issue 1, pp. 10-14, has been republished on October 1, 2015, to correct some errors in the text as well as errors in the references. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected article are provided here for reference.
Supporting Information
S1 File. Originally published, uncorrected article.
(PDF)
Click here for additional data file. (588.4KB, pdf)
S2 File. Republished, corrected article.
(PDF)
Click here for additional data file. (917.2KB, pdf)
REFERENCE
- 1.Ramzi Mani, Rezvani Aliraza, Dehghani Mehdi. GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study. Int J Hematol Oncol Stem Cell Res. 2015;9(1):10–14. [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
S1 File. Originally published, uncorrected article.
(PDF)
Click here for additional data file. (588.4KB, pdf)
S2 File. Republished, corrected article.
(PDF)
Click here for additional data file. (917.2KB, pdf)